Female Investigations

Day 2–Day 3 Hormone Profile Test

This test measures key hormones that regulate the reproductive cycle, offering valuable insights into a woman’s fertility. The hormones include:

• Follicle-Stimulating Hormone (FSH): Stimulates the growth of ovarian follicles, each containing an egg.
• Luteinizing Hormone (LH): Triggers the release of a mature egg from the ovary.
• Estradiol (E2): A form of estrogen that thickens the uterine lining for implantation.
• Prolactin: Supports lactation but can disrupt ovulation when elevated (hyperprolactinemia).
• Thyroid Stimulating Hormone (TSH): Regulates thyroid function, essential for reproductive health.

Timing and Procedure:

This test is done between Day 2 and Day 3 of the menstrual cycle, requiring a small blood sample (2-3 ml) to evaluate hormone levels. The results help assess ovarian function and predict response to ovarian stimulation medications if needed.

Anti-Müllerian Hormone (AMH) Test

The AMH test assesses the reserve of egg follicles in the ovaries and predicts how well the ovaries may respond to stimulation during fertility treatments.

• Age and AMH Levels: AMH levels decrease with age, particularly after 35, which may indicate diminished ovarian reserve.

Timing and Procedure:

This test is not cycle-dependent and can be done anytime. It requires a small blood sample (2-3 ml).

Day 21 (Mid-Luteal) Progesterone/Ovulation Test

This test assesses whether ovulation has occurred by measuring progesterone levels, typically taken on Day 21 of a 28-day cycle.

Additional Hormonal Evaluations:

For individuals with irregular cycles, additional hormone tests like FSH, LH, and thyroid function assessments may be conducted to provide a comprehensive hormonal profile.

Ultrasound Diagnostics in Female Infertility

Ultrasound scans are non-invasive and provide real-time insights into reproductive structures. Key assessments include:

• Ovarian Evaluation: Checking for cysts, endometriomas, and ovarian reserve.
• Endometrial Assessment: Evaluating the thickness and pattern of the uterine lining for successful implantation.
• Uterine Structure: Assessing for fibroids, polyps, or congenital anomalies.

Hysterosalpingogram (HSG)

An HSG is a specialized X-ray procedure to evaluate the patency of the fallopian tubes and the contour of the uterus.

Timing and Procedure:

Conducted post-menstruation and pre-ovulation (between cycle days 5–10), a small catheter is inserted into the uterus to inject a contrast dye, and X-rays are taken to assess the structure.

Sono-Hysterogram (Sono-HSG)

This test is similar to HSG but uses saline and ultrasound instead of radiation to assess the uterine cavity for abnormalities such as polyps or fibroids.

Timing and Procedure:

The test is done between cycle days 5–10, involving the insertion of a catheter and saline, followed by ultrasound imaging.

Mock Embryo Transfer

A mock embryo transfer simulates the actual procedure to measure the cervical patency and uterine depth, ensuring a smooth transfer during IVF.

Procedure:

This painless test is done between Day 1 and Day 3 of the menstrual cycle and lasts around 15–20 minutes.

Routine Health and Fertility Tests

In addition to fertility-specific tests, routine health checks are essential for overall reproductive health:

• Blood and RH Group: Determines compatibility between partners and potential pregnancy risks.
• Genotype: Identifies genetic variations affecting fertility.
• Random Blood Sugar: Monitors glucose levels for managing conditions like diabetes.
• Infectious Disease Screening: Anti-HIV, Anti-HCV, VDRL, and HBsAg tests ensure reproductive health and safety.

At Viva Fertility Clinic, we understand that accurate fertility assessments are crucial for making informed decisions and developing personalized treatment plans. Our IVF team upholds the highest standards of care, providing a nurturing and supportive environment at every step of your fertility journey.

See Male Fertility Investigations